6446 — PHARMAESSENTIA Share Price
0.000.00%
Last trade - 00:00- TWD170.18bn
- TWD150.08bn
- TWD9.73bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 25.58 | ||
| PEG Ratio (f) | 0.59 | ||
| EPS Growth (f) | 75.59% | ||
| Dividend Yield (f) | 1.15% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.04 | ||
| Price to Tang. Book | 6.1 | ||
| Price to Free Cashflow | 101.02 | ||
| Price to Sales | 17.05 | ||
| EV to EBITDA | 69.36 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.09% | ||
| Return on Equity | 11.54% | ||
| Operating Margin | 17.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 557.26 | 656.51 | 2,882.04 | 5,105.61 | 9,734.81 | 15,550.39 | 22,302.32 | 99.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +78.62 | +71.94 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 9th, 2000
- Public Since
- March 11th, 2014
- No. of Employees
- 131
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 333,042,141
- Address
- 13F, TAIPEI, 115
- Web
- https://www.pharmaessentia.com/
- Phone
- +886 226557688
- Auditors
- Ernst & Young LLP
Upcoming Events for 6446
Q2 2025 PharmaEssentia Corp Earnings Release
Similar to 6446
Abnova Taiwan
Taiwan Stock Exchange
Applied BioCode
Taiwan Stock Exchange
Energenesis Biomedical Co
Taiwan Stock Exchange
Kim Forest Enterprise Co
Taiwan Stock Exchange
Pell Bio Med Technology Co
Taiwan Stock Exchange
FAQ
What is the PHARMAESSENTIA share price?
As of Today at 22:35 UTC, shares in PHARMAESSENTIA are trading at TWD498.50. This share price information is delayed by 15 minutes.
How has the PHARMAESSENTIA share price performed this year?
Shares in PHARMAESSENTIA last closed at TWD498.50 and the price had moved by +72.79% over the past 365 days. In terms of relative price strength the PHARMAESSENTIA share price has outperformed the FTSE Developed Asia Pacific Index by +74.76% over the past year.
What are the analyst and broker recommendations for PHARMAESSENTIA?
The overall consensus recommendation for PHARMAESSENTIA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the PHARMAESSENTIA dividend yield?
The PHARMAESSENTIA dividend yield is 0.22% based on the trailing twelve month period.
Does PHARMAESSENTIA pay a dividend?
Last year, PHARMAESSENTIA paid a total dividend of TWD1.10, and it currently has a trailing dividend yield of 0.22%. We do not have any data on when PHARMAESSENTIA is to next pay dividends.
When does PHARMAESSENTIA next pay dividends?
We do not have data on when PHARMAESSENTIA is to next pay dividends. The historic dividend yield on PHARMAESSENTIA shares is currently 0.22%.
How do I buy PHARMAESSENTIA shares?
To buy shares in PHARMAESSENTIA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of PHARMAESSENTIA?
As of the previous close price of TWD498.50, shares in PHARMAESSENTIA had a market capitalisation of TWD170.18bn.
Where are PHARMAESSENTIA shares listed?
Here are the trading details for PHARMAESSENTIA:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6446
What kind of share is PHARMAESSENTIA?
Based on an overall assessment of its quality, value and momentum PHARMAESSENTIA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a PHARMAESSENTIA share price forecast for 2025?
The analyst consensus target price for shares in PHARMAESSENTIA is TWD747.99. That is 50.05% above the last closing price of TWD498.50.
Analysts covering PHARMAESSENTIA currently have a consensus Earnings Per Share (EPS) forecast of TWD15.86 for the next financial year.
Find out moreWhat is the trend in the PHARMAESSENTIA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PHARMAESSENTIA. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -18.23%.
As of the last closing price of TWD498.50, shares in PHARMAESSENTIA were trading -20.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the PHARMAESSENTIA PE Ratio?
The PHARMAESSENTIA PE ratio based on its reported earnings over the past 12 months is 25.58. The shares last closed at TWD498.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of PHARMAESSENTIA?
We do not have data on PHARMAESSENTIA's directors